Maccon Keane
University Hospital Galway · 136 works · 9,653 citations · h-index 34
Top works
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
- Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
- Breast-cancer Adjuvant Therapy With Zoledronic Acid
- Fas expression and function in normal and malignant breast cell lines.
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase
- cbl-3: a new mammalian cbl family protein
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
- Prevalence and Significance of Asymptomatic Venous Thromboembolic Disease Found on Oncologic Staging CT
- Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
- cbl-b inhibits epidermal growth factor receptor signaling
- TRAIL receptor signalling and modulation: Are we on the right TRAIL?
- Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy
- The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.
- Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- Abstract S4-5: Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer. The AZURE Trial (BIG 01/04)